<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/"><channel><title>PeptideScanner evidence for Nafarelin</title><link>https://peptidescanner.com/peptides/nafarelin/</link><description>Versioned, source-linked PeptideScanner evidence objects for Nafarelin. Selected coverage; not medical advice.</description><language>en-us</language><atom:link href="https://peptidescanner.com/feeds/peptides/nafarelin.xml" rel="self" type="application/rss+xml"/><item><title>ClinicalTrials.gov record NCT00034047</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00034047-nafarelin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00034047-nafarelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/nafarelin.json#clinicaltrials-gov-nct00034047-nafarelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2008-01-25. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT02865681</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct02865681-nafarelin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct02865681-nafarelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/nafarelin.json#clinicaltrials-gov-nct02865681-nafarelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2019-03-19. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>Drugs@FDA application NDA019886</title><link>https://peptidescanner.com/stories/fda-drugs-nda019886/</link><guid isPermaLink="false">urn:peptidescanner:story:fda-drugs-nda019886:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/nafarelin.json#fda-drugs-nda019886-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Regulatory; date in source 1990-02-13. PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.</description><dc:date>2026-11-16</dc:date><category>Regulatory</category><category>Lifecycle state: current</category></item><item><title>Clinical use of nafarelin in the treatment of leiomyomas. A review of the literature.</title><link>https://peptidescanner.com/stories/pubmed-pmid-10900582-nafarelin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-10900582-nafarelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/nafarelin.json#pubmed-pmid-10900582-nafarelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2013-11-21. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Ovarian hyperstimulation after the sole use of a gonadotrophin-releasing hormone agonist (Nafarelin) as a complication of in vitro fertilisation treatment.</title><link>https://peptidescanner.com/stories/pubmed-pmid-11495415-nafarelin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-11495415-nafarelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/nafarelin.json#pubmed-pmid-11495415-nafarelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2019-05-15. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>[Nafarelin acetate (Synarel) and thermocoagulation in the treatment of endometriosis].</title><link>https://peptidescanner.com/stories/pubmed-pmid-11526758-nafarelin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-11526758-nafarelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/nafarelin.json#pubmed-pmid-11526758-nafarelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2017-03-03. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Nafarelin in the management of endometriosis: quality of life assessment.</title><link>https://peptidescanner.com/stories/pubmed-pmid-1531576-nafarelin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-1531576-nafarelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/nafarelin.json#pubmed-pmid-1531576-nafarelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2019-06-15. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>On the origin and significance of serum CA-125 concentrations in 97 patients with endometriosis before, during, and after buserelin acetate, nafarelin, or danazol.</title><link>https://peptidescanner.com/stories/pubmed-pmid-1533376-nafarelin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-1533376-nafarelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/nafarelin.json#pubmed-pmid-1533376-nafarelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2019-07-07. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>[Some possibilities for application of &quot;Pfizer&quot; medicines--Prostin 15m, Prostin E2, Prepidil gel, Dostinex, Synarel--in the obstetrician practice].</title><link>https://peptidescanner.com/stories/pubmed-pmid-18173008-nafarelin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-18173008-nafarelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/nafarelin.json#pubmed-pmid-18173008-nafarelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2018-12-01. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>A comparative treatment trial of endometriosis using the gonadotrophin-releasing hormone agonist, nafarelin, and the synthetic steroid, danazol.</title><link>https://peptidescanner.com/stories/pubmed-pmid-1834049-nafarelin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-1834049-nafarelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/nafarelin.json#pubmed-pmid-1834049-nafarelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2019-08-28. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Longitudinal precision of dual-energy x-ray absorptiometry in a multicenter study. The Nafarelin/Bone Study Group.</title><link>https://peptidescanner.com/stories/pubmed-pmid-2028837-nafarelin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-2028837-nafarelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/nafarelin.json#pubmed-pmid-2028837-nafarelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2007-11-15. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Nafarelin: a new medical therapy for endometriosis.</title><link>https://peptidescanner.com/stories/pubmed-pmid-2137620-nafarelin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-2137620-nafarelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/nafarelin.json#pubmed-pmid-2137620-nafarelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2013-11-21. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Nafarelin in the treatment of pelvic pain caused by endometriosis.</title><link>https://peptidescanner.com/stories/pubmed-pmid-2137972-nafarelin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-2137972-nafarelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/nafarelin.json#pubmed-pmid-2137972-nafarelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2019-06-15. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Comparison of the pharmacology of nafarelin and danazol.</title><link>https://peptidescanner.com/stories/pubmed-pmid-2137975-nafarelin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-2137975-nafarelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/nafarelin.json#pubmed-pmid-2137975-nafarelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2019-06-15. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Nafarelin versus danazol in the treatment of endometriosis.</title><link>https://peptidescanner.com/stories/pubmed-pmid-2137976-nafarelin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-2137976-nafarelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/nafarelin.json#pubmed-pmid-2137976-nafarelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2019-06-15. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>A comparison of nafarelin acetate and danazol in the treatment of endometriosis.</title><link>https://peptidescanner.com/stories/pubmed-pmid-2140996-nafarelin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-2140996-nafarelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/nafarelin.json#pubmed-pmid-2140996-nafarelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2019-07-07. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>An attempt to alter the pathophysiology of polycystic ovary syndrome using a gonadotrophin hormone releasing hormone agonist--Nafarelin.</title><link>https://peptidescanner.com/stories/pubmed-pmid-2533526-nafarelin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-2533526-nafarelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/nafarelin.json#pubmed-pmid-2533526-nafarelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-11-09. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Role of nafarelin in the management of endometriosis.</title><link>https://peptidescanner.com/stories/pubmed-pmid-2533616-nafarelin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-2533616-nafarelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/nafarelin.json#pubmed-pmid-2533616-nafarelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2013-11-21. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Clinical experience treating endometriosis with nafarelin.</title><link>https://peptidescanner.com/stories/pubmed-pmid-2533617-nafarelin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-2533617-nafarelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/nafarelin.json#pubmed-pmid-2533617-nafarelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2013-11-21. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Experience in the use of nafarelin for treatment of benign breast disease.</title><link>https://peptidescanner.com/stories/pubmed-pmid-2535115-nafarelin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-2535115-nafarelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/nafarelin.json#pubmed-pmid-2535115-nafarelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2013-11-21. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Absorption and metabolism of nafarelin, a potent agonist of gonadotropin-releasing hormone.</title><link>https://peptidescanner.com/stories/pubmed-pmid-2970910-nafarelin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-2970910-nafarelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/nafarelin.json#pubmed-pmid-2970910-nafarelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2019-05-10. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Endometriosis with a pleural effusion and ascites. Report of a case treated with nafarelin acetate.</title><link>https://peptidescanner.com/stories/pubmed-pmid-7473446-nafarelin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-7473446-nafarelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/nafarelin.json#pubmed-pmid-7473446-nafarelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2016-11-23. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>[The use of Synarel (nafarelin acetate--spray) in gynecology].</title><link>https://peptidescanner.com/stories/pubmed-pmid-7485786-nafarelin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-7485786-nafarelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/nafarelin.json#pubmed-pmid-7485786-nafarelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2017-11-16. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Severe hyperkalaemia with nafarelin.</title><link>https://peptidescanner.com/stories/pubmed-pmid-8569395-nafarelin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-8569395-nafarelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/nafarelin.json#pubmed-pmid-8569395-nafarelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2019-06-11. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Iontophoresis of nafarelin across human skin in vitro.</title><link>https://peptidescanner.com/stories/pubmed-pmid-8860440-nafarelin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-8860440-nafarelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/nafarelin.json#pubmed-pmid-8860440-nafarelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2019-08-18. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>A double-blind randomized study of the treatment of endometriosis with nafarelin or nafarelin plus norethisterone.</title><link>https://peptidescanner.com/stories/pubmed-pmid-9209899-nafarelin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-9209899-nafarelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/nafarelin.json#pubmed-pmid-9209899-nafarelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2019-11-02. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Use of nafarelin versus placebo after reductive laparoscopic surgery for endometriosis.</title><link>https://peptidescanner.com/stories/pubmed-pmid-9389816-nafarelin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-9389816-nafarelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/nafarelin.json#pubmed-pmid-9389816-nafarelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2019-07-07. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Pre or post-operative medical treatment with nafarelin in stage III-IV endometriosis: a French multicenter study.</title><link>https://peptidescanner.com/stories/pubmed-pmid-9720832-nafarelin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-9720832-nafarelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/nafarelin.json#pubmed-pmid-9720832-nafarelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2019-08-16. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item></channel></rss>
